{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:20:40Z","timestamp":1788326440762,"version":"build-2803163510"},"reference-count":22,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"Importance<\/jats:title>Cerebral amyloid angiopathy (CAA) is a common cause of spontaneous intracerebral hemorrhage in older patients. Although other types of intracranial hemorrhage can occur in conjunction with CAA-related intracerebral hemorrhage, the association between CAA and other subtypes of intracranial hemorrhage, particularly in the absence of intracerebral hemorrhage, remains poorly understood.<\/jats:p><\/jats:sec>Objective<\/jats:title>To determine whether CAA is an independent risk factor for isolated nontraumatic subdural hemorrhage (SDH).<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>A population-based cohort study was performed using a 2-stage analysis of prospectively collected data in the UK Biobank cohort (discovery phase, 2006-2022) and the All of Us Research Program cohort (replication phase, 2018-2022). Participants included those who contributed at least 1 year of data while they were older than 50 years, in accordance with the diagnostic criteria for CAA. Participants with prevalent intracranial hemorrhage were excluded. Data were analyzed from October 2022 to October 2023.<\/jats:p><\/jats:sec>Exposure<\/jats:title>A diagnosis of CAA, identified using the International Classification of Diseases, Tenth Revision, Clinical Modification<\/jats:italic> (ICD-10-CM<\/jats:italic>) diagnosis code.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The outcome was an isolated nontraumatic SDH, identified using ICD-10-CM<\/jats:italic> codes. Two identical analyses were performed separately in the 2 cohorts. First, the risk of SDH in patients with and without CAA was assessed using Cox proportional hazards models, adjusting for demographic characteristics, cardiovascular comorbidities, and antithrombotic medication use. Second, multivariable logistic regression was used to study the association between CAA and SDH.<\/jats:p><\/jats:sec>Results<\/jats:title>The final analytical sample comprised 487\u202f223 of the total 502\u202f480 individuals in the UK Biobank cohort and 158\u202f008 of the total 372\u202f082 individuals in the All of Us cohort. Among the 487\u202f223 participants in the discovery phase of the UK Biobank, the mean (SD) age was 56.5 (8.1) years, and 264\u202f195 (54.2%) were female. There were 649 cases of incident SDH. Of the 126 participants diagnosed with CAA, 3 (2.4%) developed SDH. In adjusted Cox regression analyses, participants with CAA had an increased risk of having an SDH compared with those without CAA (hazard ratio [HR], 8.0; 95% CI, 2.6-24.8). Multivariable logistic regression analysis yielded higher odds of SDH among participants with CAA (odds ratio [OR], 7.6; 95% CI, 1.8-20.4). Among the 158\u202f008 participants in the All of Us cohort, the mean (SD) age was 63.0 (9.5) years, and 89\u202f639 (56.7%) were female. The findings were replicated in All of Us, in which 52 participants had CAA and 320 had an SDH. All of Us participants with CAA had an increased risk of having an SDH compared with those without CAA (HR, 4.9; 95% CI, 1.2-19.8). In adjusted multivariable logistic regression analysis, CAA was associated with higher odds of SDH (OR, 5.2; 95% CI, 0.8-17.6).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In 2 large, heterogeneous cohorts, CAA was associated with increased risk of SDH. These findings suggest that CAA may be a novel risk factor for isolated nontraumatic SDH.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaneurol.2023.4918","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T16:00:30Z","timestamp":1703606430000},"page":"163","source":"Crossref","is-referenced-by-count":21,"title":["Cerebral Amyloid Angiopathy and Risk of Isolated Nontraumatic Subdural Hemorrhage"],"prefix":"10.1001","volume":"81","author":[{"given":"Cyprien A.","family":"Rivier","sequence":"first","affiliation":[{"name":"Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, Connecticut"},{"name":"Yale Center for Brain and Mind Health, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooman","family":"Kamel","sequence":"additional","affiliation":[{"name":"Deputy Editor, JAMA Neurology"},{"name":"Clinical and Translational Neuroscience Unit, Department of Neurology, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin N.","family":"Sheth","sequence":"additional","affiliation":[{"name":"Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, Connecticut"},{"name":"Yale Center for Brain and Mind Health, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"Iadecola","sequence":"additional","affiliation":[{"name":"Clinical and Translational Neuroscience Unit, Department of Neurology, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Gupta","sequence":"additional","affiliation":[{"name":"Brain Health Imaging Institute, Department of Radiology, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mony J.","family":"de Leon","sequence":"additional","affiliation":[{"name":"Brain Health Imaging Institute, Department of Radiology, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ross","sequence":"additional","affiliation":[{"name":"Center for Neurogenetics, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido J.","family":"Falcone","sequence":"additional","affiliation":[{"name":"Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, Connecticut"},{"name":"Yale Center for Brain and Mind Health, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh B.","family":"Murthy","sequence":"additional","affiliation":[{"name":"Clinical and Translational Neuroscience Unit, Department of Neurology, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7","key":"noi230091r1","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1097\/CCM.0b013e3182186ed6","article-title":"National trend in prevalence, cost, and discharge disposition after subdural hematoma from 1998-2007.","volume":"39","author":"Frontera","year":"2011","journal-title":"Crit Care Med"},{"issue":"5","key":"noi230091r2","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3171\/2014.9.JNS141550","article-title":"Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations.","volume":"123","author":"Balser","year":"2015","journal-title":"J Neurosurg"},{"issue":"3","key":"noi230091r3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4103\/0976-3147.118760","article-title":"Neurological and functional outcomes of subdural hematoma evacuation in patients over 70 years of age.","volume":"4","author":"Mulligan","year":"2013","journal-title":"J Neurosci Rural Pract"},{"issue":"10","key":"noi230091r4","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nrneurol.2014.163","article-title":"Chronic subdural haematoma: modern management and emerging therapies.","volume":"10","author":"Kolias","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"noi230091r5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3171\/jns.1982.57.2.0254","article-title":"Acute subdural hematoma: review of 39 consecutive cases with high incidence of cortical artery rupture.","volume":"57","author":"Shenkin","year":"1982","journal-title":"J Neurosurg"},{"issue":"3-4","key":"noi230091r6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/BF03402043","article-title":"Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer\u2019s disease.","volume":"9","author":"Roher","year":"2003","journal-title":"Mol Med"},{"issue":"1","key":"noi230091r7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/archneur.66.1.79","article-title":"Association of subdural hematoma with increased mortality in lobar intracerebral hemorrhage.","volume":"66","author":"Patel","year":"2009","journal-title":"Arch Neurol"},{"issue":"6","key":"noi230091r8","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1161\/STROKEAHA.119.024837","article-title":"Subarachnoid and subdural hemorrhages in lobar intracerebral hemorrhage associated with cerebral amyloid angiopathy.","volume":"50","author":"Viguier","year":"2019","journal-title":"Stroke"},{"issue":"7726","key":"noi230091r9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data.","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"issue":"7","key":"noi230091r10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1056\/NEJMsr1809937","article-title":"The \u201cAll of Us\u201d Research Program.","volume":"381","author":"Denny","year":"2019","journal-title":"N Engl J Med"},{"issue":"8","key":"noi230091r11","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","article-title":"The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.","volume":"21","author":"Charidimou","year":"2022","journal-title":"Lancet Neurol"},{"issue":"7","key":"noi230091r12","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/pds.v28.7","article-title":"Assessment of ICD-10-CM code assignment validity for case finding of outpatient anticoagulant-related bleeding among Medicare beneficiaries.","volume":"28","author":"Shehab","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1874","key":"noi230091r13","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1098\/rsta.2008.0037","article-title":"Improving interval estimation of binomial proportions.","volume":"366","author":"Zhou","year":"2008","journal-title":"Philos Trans A Math Phys Eng Sci"},{"issue":"8","key":"noi230091r14","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/jama.2017.0639","article-title":"Association of antithrombotic drug use with subdural hematoma risk.","volume":"317","author":"Gaist","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"noi230091r15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals.","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"issue":"446","key":"noi230091r16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"27","key":"noi230091r17","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/sim.v36.27","article-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data.","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"issue":"1","key":"noi230091r18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1227\/00006123-198401000-00004","article-title":"Spontaneous arterial subdural hematoma.","volume":"14","author":"McDermott","year":"1984","journal-title":"Neurosurgery"},{"issue":"7","key":"noi230091r19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00701-003-0020-7","article-title":"A clinical comparison of non-traumatic acute subdural haematomas either related to coagulopathy or of arterial origin without coagulopathy.","volume":"145","author":"Depreitere","year":"2003","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"noi230091r20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jstrokecerebrovasdis.2006.11.007","article-title":"Clinical investigation of acute spontaneous subdural hematoma cases.","volume":"16","author":"Akioka","year":"2007","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"4","key":"noi230091r21","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1007\/s00415-021-10937-4","article-title":"Recurrent intracerebral hemorrhage in patients with cerebral amyloid angiopathy: a propensity-matched case-control study.","volume":"269","author":"Garg","year":"2022","journal-title":"J Neurol"},{"key":"noi230091r22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jocn.2021.04.021","article-title":"Disparities in diagnosis of cerebral amyloid angiopathy based on hospital characteristics.","volume":"89","author":"Nagaraja","year":"2021","journal-title":"J Clin Neurosci"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2813440\/jamaneurology_rivier_2023_oi_230091_1707344392.4156.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T16:02:06Z","timestamp":1707753726000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2813440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2023.4918","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}